India-based nutraceutical manufacturer Zeus Hygia to use new capital to scale international operations, invest in R&D, and expand its portfolio of clinically backed herbal ingredients
Zeus Hygia, an Indian nutraceutical ingredient manufacturer, has raised USD 2.5 million in Series A funding from NABVENTURES, the venture capital arm of the National Bank for Agriculture and Rural Development (NABARD). The investment will support the company’s next phase of product development and international market expansion.
Founded by Dr Arunkanth Krishnakumar (Ph.D.) and Mr. Shankaranarayanan Jeyakodi (M. Pharm.), Zeus Hygia focuses on the development of safe, effective, and evidence-backed herbal extracts for the wellness industry. The company currently offers eight branded and clinically validated ingredients: BioSOLVE Curcumin, CaroTex, Grantria, GreMin, Stadice, Gevalin, Metaberine, and Consolax. Several additional products are under development.
The funding will enable Zeus Hygia to accelerate its R&D pipeline, particularly in areas such as pain management, weight management, performance enhancement, women’s health, and healthy ageing.
“We’re at an exciting inflection point in our journey,” said Dr Arunkanth Krishnakumar, Co-founder and CEO of Zeus Hygia. “This funding from NABVENTURES validates our scientific approach and gives us the momentum to bring innovative, clinically backed nutraceutical solutions to a global audience. Our goal is to set new benchmarks for quality and efficacy in the wellness industry.”
Ankita Bhatnagar, Vice President at NABVENTURES, commented, “Zeus Hygia’s innovative approach to developing high-value nutraceutical ingredients from India-based plant products is a game-changer. This not only unlocks significant potential for our farmers to cultivate crops with enhanced economic returns but also addresses the global demand for natural ingredients. Zeus Hygia stands out with its commitment to clinically validated, patented, plant-based solutions, positioning India at the forefront of the global nutraceutical landscape and fostering a vibrant ecosystem of agricultural prosperity and global well-being.”
Zeus Hygia currently exports to over 15 countries and has established a unit in the United States to strengthen its presence in the North American market. The company is also expanding its reach in Southeast Asia, with further plans to increase focus on the APAC and MENA regions.
Over the next three years, Zeus Hygia aims to grow its international footprint through direct operations and strategic partnerships. The company expects nearly 70 per cent of its revenue to be generated from global markets. It has recently entered into joint venture development projects with Japanese and Korean nutraceutical and FMCG companies, with commercial launches expected within the next two years.
